AMBER WHITTON-SMITH: Open Payments
NPI 1689823593 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 51 payments from 22 companies in 2025. Trend: 2023 $2,378 · 2024 $1,788 · 2025 $1,282
Food & beverage: $1,189Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $175 |
| Gilead Sciences, Inc. | 5 | $145 |
| GlaxoSmithKline, LLC. | 5 | $135 |
| Daiichi Sankyo Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Genentech USA, Inc. | 3 | $71 |
| SOBI, INC | 2 | $53 |
| Eisai Inc. | 2 | $52 |
| Astellas Pharma US Inc | 2 | $50 |
| BeiGene USA, Inc. | 2 | $48 |
Products named: Trodelvy, ERLEADA, OJJAARA, Enhertu, RYBREVANT, JEMPERLI, TEVIMBRA, KISQALI.
Industry payments across CO — which companies pay providers there.
